Urine diagnostic tool for the detection of high-grade prostate cancer
Ended Project Grant Awarded Last action
- Award ID
- R44CA254692
- Recipient
-
Lynx DX Inc. UEI CVMDCVXNU3K1
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,990,296
Award facts
- Assistance listing
- 93.394 Cancer Detection and Diagnosis Research
- Completion date
- Funding
-
- $2,994,969.00 Federal
- $995,327.00 Non-federal
- Place of performance
- Michigan, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $995,327 | $0 | |
| Amendment | $995,327 | $995,327 | |
| Original award | $1,004,315 | $0 |
Quick answers
Who received award R44CA254692?
R44CA254692 was awarded to Lynx DX Inc. by National Cancer Institute (National Institutes of Health) on September 1, 2020.
How much is award R44CA254692 worth?
$3,990,296 has been obligated on R44CA254692: $2,994,969 in federal funding and $995,327 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award